Effect of systemic administration of synthetic pyrimidine derivatives, xymedon and compounds 29D and 34D, was studied in rats with experimental dosed contusion spinal cord injury. Xymedon promoted recovery of motor function after injury. Compounds 29D and 34D more effectively restored the parameters of open-field and Rotarod tests in comparison with xymedon. Compound 29D more effectively than xymedon maintained the number of Olig2+ oligodendrocytes in the corticospinal tract and NG2 cells in all investigated areas of the white matter. In the group treated with compound 34D, the differences in the number of NG2+ cells were revealed only in the anterior funiculi, where the number of these glial cells was 2-fold higher than in the xymedon-treated group. Obtained results suggest that the studied xymedon analogs, compounds 29D and 34D, can exert their therapeutic action through different molecular and cellular pathways.
Similar content being viewed by others
References
Lebedev SV, Timofeyev SV, Zharkov AV, Schipilov VG, Chelyshev JA, Masgutova GA, Chekhonin VP. Exercise tests and BBB method for evaluation of motor disorders in rats after contusion spinal injury. Bull. Exp. Biol. Med. 2008;146(4):489-494.
Raginov IS, Chelyshev YuA, Khafiz’yanova RKh. Effect of xymedone on posttraumatic survival of sensory neurons. Bull. Exp. Biol. Med. 2000;129(3):216-218.
Raginov IS, Chelyshev YA, Shagidullin TF. Effect of xymedon on cell survival in the system sensory neuron Schwann cell Bull. Exp. Biol. Med. 2001;131(3):229-230.
Chelyshev YuA, Khafiz’yanova RKh, Raginov IS, Vafin AYu. Drug-stimulated regeneration of a peripheral nerve. Eksp. Klin. Farmakol. 2000;63(4):17-19. Russian.
Fujiwara T, Morimoto K. A compound CP-31398 suppresses excitotoxicity-induced neurodegeneration. Biochem. Biophys. Res. Commun. 2013;440(3):359-363.
Itoh S, Samejima H, Shinomiya K, Awaya A. The effect of neurotrophic pyrimidine heterocyclic compounds, MS-818 and MS-430, on the regeneration of injured peripheral nerves. Restor. Neurol. Neurosci. 1999;14(4):265-273.
Masgutov R, Raginov I, Fomina G, Kozlova M, Chelyshev Y. Stimulation of the rat’s sciatic nerve regeneration by local treatment with xymedon. Cell Mol. Neurobiol. 2006;26(7-8):1413-1421.
Matsumoto K, Yamamoto K, Karasawa Y, Hino N, Nakamura A, Takahashi M, Araki H, Okuyama S, Choshi T, Sugino E, Hibino S, Yoshimoto M. Possible involvement of induction of brain-derived neurotrophic factor in the neuroprotective effect of a 5-phenylpyrimidine derivative. Biochem. Pharmacol. 2003;66(6):1019-1023.
Mitsuyama T, Kawamata T, Yamane F, Awaya A, Hori T. Role of a synthetic pyrimidine compound, MS-818, in reduction of infarct size and amelioration of sensorimotor dysfunction following permanent focal cerebral ischemia in rats. J. Neurosurg. 2002;96(6):1072-1076.
Ochi M, Noda M, Nakamitsu K, Deie M, Ikuta Y, Maki Y, Awaya A. Promotion of sciatic nerve regeneration in rats by a new neurotrophic pyrimidine derivative MS-430. Gen. Pharmacol. 1995;26(1):59-64.
Sanjo N, Owada K, Kobayashi T, Mizusawa H, Awaya A, Michikawa M. A novel neurotrophic pyrimidine compound MS-818 enhances neurotrophic effects of basic fibroblast growth factor. J. Neurosci. Res. 1998;54(5):604-612.
Sharma M, Deekshith V, Semwal A, Sriram D, Yogeeswari P. Discovery of tetrahydropyrido[4,3-d]pyrimidine derivatives for the treatment of neuropathic pain. Bioorg. Chem. 2014;52): 69-76.
Sharp KG, Yee KM, Steward O. A re-assessment of treatment with a tyrosine kinase inhibitor (imatinib) on tissue sparing and functional recovery after spinal cord injury. Exp. Neurol. 2014;254:1-11.
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 161, No. 8, pp. 183-187, August, 2016
Rights and permissions
About this article
Cite this article
Povysheva, T.V., Semenov, V.E., Galyametdinova, I.V. et al. New Xymedon Analogues for Stimulation of Posttraumatic Regeneration of the Spinal Cord in Rats. Bull Exp Biol Med 162, 220–224 (2016). https://doi.org/10.1007/s10517-016-3580-2
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10517-016-3580-2